Skip to main content
. 2020 Jun 12;11:2976. doi: 10.1038/s41467-020-16782-9

Table 3.

Serious adverse events.

Serious adverse events NIHP (n = 6) SCS (n = 25) RR
Acute cardiac failure 0 3 (12%)
Acute bleeding (BARC type IV)a 0 6 (24%)
Respiratory failure 2 (33%) 8 (32%) 1.04 (0.29–3.7)
Acute kidney failure (KDIGO)a 5 (83%) 17 (68%) 1.23 (0.78–1.9)
Acute liver failure 0 0
Permanent stroke 0 0
Permanent pacemaker 0 4 (16%)

Data are n (%).

NIHP nonischemic heart preservation, RR relative risk, SCS static cold storage.

aFor definition see online methods.